Search results
Pfizer agrees to settle over 10K lawsuits linking Zantac to cancer
New York Post· 16 hours agoPfizer has agreed to settle more than 10,000 lawsuits which alleged that the company failed to warn...
Pfizer agrees to settle over 10,000 Zantac lawsuits, Bloomberg News reports
Reuters via Yahoo News· 18 hours agoThe agreements cover cases in U.S. state courts but don't completely resolve the company's exposure...
Second Death - Pfizer Reports Young Boy's Death After One Year Of Gene Therapy Treatment In Muscle...
Benzinga via Yahoo Finance· 13 hours agoA young patient died due to cardiac arrest after receiving Pfizer Inc’s (NYSE:PFE) experimental gene...
Pfizer Inc's Dividend Analysis
GuruFocus.com via Yahoo Finance· 21 hours agoPfizer Inc (NYSE:PFE) recently announced a dividend of $0.42 per share, payable on 2024-06-14, with the ex-dividend date set for 2024-05-09. As investors...
Pfizer Agrees to Settle More Than 10,000 Zantac Cancer Lawsuits
Insurance Journal· 17 hours agoPfizer Inc. has agreed to settle more than 10,000 cases accusing it of hiding the cancer risks of...
Pfizer pauses phase 3 dosing in gene therapy trial after young boy's death
FierceBiotech· 1 day agoA young boy with Duchenne muscular dystrophy (DMD) participating in Pfizer’s phase 2 gene therapy...
Is Pfizer Stock Fully Valued At $28?
Forbes· 2 days agoPfizer (NYSE: PFE) reported its Q1 results last week, with revenues and earnings beating the street estimates.
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 16 hours agoPfizer stock jumped to its 50-day moving average in early May after the company beat first-quarter...
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Reuters via Yahoo Finance· 2 weeks ago(Reuters) -GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 1 week agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...